Realyze Intelligence Technology Enables Multidisciplinary Study Aimed at Reducing the Overtreatment of Breast Cancer
Leveraging the capabilities of Realyze Intelligence technology, a group of researchers from UPMC Hillman Cancer Center, Institute for Precision Medicine, & University of Pittsburgh have published in JAMA Surgery. The study shows how real-world-data-led insights improve breast cancer patient care.
Realyze Intelligence Powers Groundbreaking Breast Cancer Study Published in the Journal of Clinical Oncology – Clinical Cancer Informatics
Realyze Intelligence technology has powered a groundbreaking research study that will inform more personalized care pathways and improve the quality of life for breast cancer patients. The research was published today in the
Journal of Clinical Oncology Clinical Cancer Informatics, an American Society of Clinical Oncology (ASCO) journal.
Realyze Joins Creative Destruction Lab’s Cancer Program Cohort to “Create Something Massive” in 2024
Realyze Intelligence is honored to announce that they have been selected by the Creative Destruction Lab (CDL) to join their current cancer program cohort.
Realyze Strengthens Board and Advisory Panel with Industry Experts
Realyze Intelligence is thrilled to share that Michael Finke and Scot Stevens have joined the company’s Board of Directors and that Carolyn Penstein Rose, PhD, will be working with the company as an Advisor.